99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
Leveraging AI to Enhance Early Detection and Management of Diabetic Retinopathy

Leveraging AI to Enhance Early Detection and Management of Diabetic Retinopathy

Recent findings from a study published in the JAMA Ophthalmology have shed light on the underutilized potential of artificial intelligence (AI) in diagnosing diabetic retinopathy (DR), despite its proven effectiveness.

Leveraging AI to Enhance Early Detection and Management of Diabetic Retinopathy

Recent findings from a study published in the JAMA Ophthalmology have shed light on the underutilized potential of artificial intelligence (AI) in diagnosing diabetic retinopathy (DR), despite its proven effectiveness.
Researchers define new subtypes of common brain disorder

Researchers define new subtypes of common brain disorder

by Mark Reynolds,Washington University School of MedicineAn MRI scan shows a Chiari type-1 malformation, in which the cerebellum extends beyond the gap in the skull where it connects to the spin

Researchers define new subtypes of common brain disorder

by Mark Reynolds,Washington University School of MedicineAn MRI scan shows a Chiari type-1 malformation, in which the cerebellum extends beyond the gap in the skull where it connects to the spin
Circuit-specific gene therapy brings new hope for treatment of Parkinson's disease

Circuit-specific gene therapy brings new hope for treatment of Parkinson's disease

byChinese Academy of SciencesRetrograde AAV selectively targets D1-MSNs and rescues parkinsonian symptoms with chemogenetic modulation. Credit: SIATResearchers from the Shenzhen Institute of Adv

Circuit-specific gene therapy brings new hope for treatment of Parkinson's disease

byChinese Academy of SciencesRetrograde AAV selectively targets D1-MSNs and rescues parkinsonian symptoms with chemogenetic modulation. Credit: SIATResearchers from the Shenzhen Institute of Adv
Blast exposure linked to intestinal problems

Blast exposure linked to intestinal problems

by Veterans Affairs Research CommunicationsCredit: Unsplash/CC0 Public DomainA study by New York and Rocky Mountain U.S. Department of Veterans Affairs researchers showed blast exposure can cause inte

Blast exposure linked to intestinal problems

by Veterans Affairs Research CommunicationsCredit: Unsplash/CC0 Public DomainA study by New York and Rocky Mountain U.S. Department of Veterans Affairs researchers showed blast exposure can cause inte
Experts release the latest guide for systematic reviews of preclinical research

Experts release the latest guide for systematic reviews of preclinical research

byRadboud UniversityCredit: Unsplash/CC0 Public DomainA new publication inNature Reviews Methods Primersprovides essential guidance for conducting rigorous systematic reviews on stud

Experts release the latest guide for systematic reviews of preclinical research

byRadboud UniversityCredit: Unsplash/CC0 Public DomainA new publication inNature Reviews Methods Primersprovides essential guidance for conducting rigorous systematic reviews on stud
Preparing for the next health crisis: COVID-19 showed the importance of community-engaged research

Preparing for the next health crisis: COVID-19 showed the importance of community-engaged research

by Simran Purewal and Julia Smith,The ConversationCredit: CC0 Public DomainCommunity-engaged researchinvolves the active and meaningful involvement of people directly affected by a researc

Preparing for the next health crisis: COVID-19 showed the importance of community-engaged research

by Simran Purewal and Julia Smith,The ConversationCredit: CC0 Public DomainCommunity-engaged researchinvolves the active and meaningful involvement of people directly affected by a researc
New drug halts growth of aggressive breast cancer in pre-clinical study

New drug halts growth of aggressive breast cancer in pre-clinical study

FEBRUARY 5, 2024by Jessica Stanley,University of AdelaideCDDD11-8 inhibits proliferation of patient-derived breast organoid models. Credit:Oncogene(2023). DOI: 10.1038/s41388-023-028

New drug halts growth of aggressive breast cancer in pre-clinical study

FEBRUARY 5, 2024by Jessica Stanley,University of AdelaideCDDD11-8 inhibits proliferation of patient-derived breast organoid models. Credit:Oncogene(2023). DOI: 10.1038/s41388-023-028
Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

by Anne Grimm,Leipzig UniversityCredit: Pixabay/CC0 Public DomainIn patients affected by myelodysplastic neoplasms, the body does not produce enough functional blood cells. Patients suffer from

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

by Anne Grimm,Leipzig UniversityCredit: Pixabay/CC0 Public DomainIn patients affected by myelodysplastic neoplasms, the body does not produce enough functional blood cells. Patients suffer from
Study of type 2 diabetes medications show differences in medication acceptance, quality-of-life, insulin secretion

Study of type 2 diabetes medications show differences in medication acceptance, quality-of-life, insulin secretion

byLouisiana State UniversityCredit: Pixabay/CC0 Public DomainDiabetes affects more than 1 in 10—or more than 38 million—Americans. People with diabetes who keep their blood sugar levels in the n

Study of type 2 diabetes medications show differences in medication acceptance, quality-of-life, insulin secretion

byLouisiana State UniversityCredit: Pixabay/CC0 Public DomainDiabetes affects more than 1 in 10—or more than 38 million—Americans. People with diabetes who keep their blood sugar levels in the n
New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainNew data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizuma

New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainNew data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizuma